“Our platform is designed to reprogram the immune system, restoring tolerance without the burden of chronic immunosuppression. By combining DNA instructions with our proprietary delivery platform, we ...
A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...
Hosted on MSN
The Promise and Perils of Reprogramming Immunity
Scientists are reprogramming the immune system through cutting-edge approaches like CAR-T cells, engineered dendritic vaccines, AI-driven antibody design, and senolytic therapies, highlighting both ...
LISBON, March 5 (Xinhua) -- Scientists have successfully created anti-tumor immune cells in a laboratory using cellular reprogramming for the first time, opening new possibilities in the fight against ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in ...
The immune system can be "reprogrammed" to heal the body faster using electrical stimulation, according to new research. Irish scientists discovered that electrically stimulating “macrophages” – one ...
For millions of people around the world, asthma is more than just a breathing problem — it is a chronic and often debilitating condition caused by the immune system's exaggerated response to harmless ...
When food is scarce, stress hormones direct the immune system to operate in "low power" mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine.
When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer. By manipulating the function ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results